The evidence for ketamine treatment in older adults with psychiatric illness: a scoping review
Therapeutic Advances in Chronic Disease October 1, 2025 Kayla Murphy, Julia C. Golden, Haley Schuster et al. 3 citations
Background: Ketamine, an N-methyl-D-aspartate antagonist, has been used for decades as an anesthetic agent, but more recently it has been studied in psychiatric illness. Though ketamine has been investigated for use in the general population, fewer studies have investigated the efficacy and tolerability of this treatment for older (age >60) adults. Objectives: This review sought to compile the...